Orion Infusion Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019

Orion Infusion Limited is a Bangladesh-based large volume parenteral (LVP) manufacturing company. The Company is a provider of quality medicines and health care services through approximately 28 brands and 42 presentations of various formulations. The Company is engaged in manufacturing and marketing of Intravenous (I.V.) fluid, lifesaving intravenous medicine and intravascular saline, which include fluid and nutrient, fluid and electrolyte, fat emulsion for I.V. use, fluid, nutrient and electrolyte, plasma substitute, antiulcerant, osmotic diuretic and amino acid solutions. The Company has the manufacturing facilities for the production of I.V. Rehydration Solutions, Electrolyte Solutions, and Solution for Acidosis, Ranitidine I.V. infusion, Anti-Microbial products viz. Ciprofloxacin I.V., Metronidazole I.V. and others. The Company's production plant is situated at Maikuli, P.S. Rupganj, and District- Naraynganj, Bangladesh.